吉林省精鑫药业集团有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
39
NMPA:39
Drug Approvals
Compound Paracetamol and Diphenhydramine Hydrochloride Tablets
- Product Name
- 复方氨酚苯海拉明片
- Approval Number
- 国药准字H22025521
- Approval Date
- Jul 29, 2020
NMPA
Erythromycin Enteric-coated Tablets
- Product Name
- 红霉素肠溶片
- Approval Number
- 国药准字H22023186
- Approval Date
- Jul 29, 2020
NMPA
Alginic Sodium Diester Tablets
- Product Name
- 藻酸双酯钠片
- Approval Number
- 国药准字H22022354
- Approval Date
- Jul 29, 2020
NMPA
Compound Aspirin tablets
- Product Name
- 复方乙酰水杨酸片
- Approval Number
- 国药准字H22022353
- Approval Date
- Jul 29, 2020
NMPA
Compound Sulfamethoxazole Tablets
- Product Name
- 复方磺胺甲噁唑片
- Approval Number
- 国药准字H22023184
- Approval Date
- Jul 29, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found